SERPINB9
Basic information
Region (hg38): 6:2887173-2903309
Previous symbols: [ "PI9" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SERPINB9 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 2 | 0 |
Variants in SERPINB9
This is a list of pathogenic ClinVar variants found in the SERPINB9 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-2890213-G-A | not specified | Uncertain significance (May 24, 2023) | ||
6-2890215-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
6-2890255-G-A | not specified | Uncertain significance (Apr 28, 2023) | ||
6-2890296-G-A | not specified | Uncertain significance (Sep 14, 2022) | ||
6-2890309-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
6-2890329-A-G | not specified | Uncertain significance (Feb 06, 2023) | ||
6-2890380-G-A | not specified | Uncertain significance (Jan 02, 2024) | ||
6-2890392-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
6-2890405-T-C | not specified | Uncertain significance (Jan 09, 2024) | ||
6-2890451-T-C | Likely benign (Aug 01, 2022) | |||
6-2890500-A-G | not specified | Uncertain significance (Oct 20, 2023) | ||
6-2890536-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
6-2890554-G-C | not specified | Uncertain significance (Sep 14, 2023) | ||
6-2891887-C-A | not specified | Uncertain significance (Dec 18, 2023) | ||
6-2891919-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
6-2893428-G-A | not specified | Uncertain significance (May 25, 2022) | ||
6-2893468-C-G | not specified | Uncertain significance (Nov 09, 2023) | ||
6-2893509-T-C | not specified | Uncertain significance (Oct 12, 2021) | ||
6-2893520-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
6-2893520-A-T | not specified | Uncertain significance (Aug 30, 2022) | ||
6-2893532-G-A | not specified | Uncertain significance (Apr 17, 2023) | ||
6-2895402-T-C | not specified | Uncertain significance (May 01, 2024) | ||
6-2895442-C-A | not specified | Uncertain significance (Oct 04, 2022) | ||
6-2895480-T-C | not specified | Uncertain significance (May 24, 2023) | ||
6-2895507-G-A | not specified | Uncertain significance (Aug 26, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SERPINB9 | protein_coding | protein_coding | ENST00000380698 | 6 | 16015 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0123 | 0.956 | 125697 | 0 | 51 | 125748 | 0.000203 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.00670 | 218 | 218 | 0.999 | 0.0000122 | 2480 |
Missense in Polyphen | 69 | 72.802 | 0.94778 | 952 | ||
Synonymous | 0.721 | 85 | 93.9 | 0.905 | 0.00000644 | 723 |
Loss of Function | 1.87 | 5 | 12.0 | 0.418 | 5.05e-7 | 148 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000155 | 0.000154 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000348 | 0.000343 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000135 | 0.000131 |
Other | 0.000337 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Granzyme B inhibitor.;
- Pathway
- Amoebiasis - Homo sapiens (human);Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway
(Consensus)
Recessive Scores
- pRec
- 0.218
Intolerance Scores
- loftool
- 0.209
- rvis_EVS
- -0.6
- rvis_percentile_EVS
- 17.91
Haploinsufficiency Scores
- pHI
- 0.447
- hipred
- N
- hipred_score
- 0.139
- ghis
- 0.572
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.159
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Serpinb9g
- Phenotype
Gene ontology
- Biological process
- mast cell mediated immunity;apoptotic process;immune response;response to bacterium;positive regulation of gene expression;negative regulation of endopeptidase activity;negative regulation by symbiont of host apoptotic process;protection from natural killer cell mediated cytotoxicity;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;cellular response to estrogen stimulus
- Cellular component
- extracellular space;nucleus;nucleoplasm;cytoplasm;Golgi apparatus;cytosol;membrane;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- protease binding;serine-type endopeptidase inhibitor activity;protein binding;cysteine-type endopeptidase inhibitor activity involved in apoptotic process